Aquarius Surgical Technologies Announces Share Issuance
Aquarius Surgical Technologies Announces Share Issuance
TORONTO, ON / ACCESSWIRE / March 25, 2022 / Aquarius Surgical Technologies Inc. (CSE:ASTI) announces that it has issued 100,000 shares to each of four non-executive directors and to corporate officers, in compensation for services, for a total of 600,000 shares. All shares were issued at a stated price of $0.065 each. The shares were issued pursuant to the prospectus exemption contained in NI 45-106 s. 2.24 and are not subject to any restrictive hold period.
加拿大多倫多/線材/2022 年 3 月 25 日/水瓶座手術技術有限公司 (CSE:阿斯蒂) 宣佈已向四名非執行董事及企業主管人員發行 10 萬股股份，以補償服務業，總共 60 萬股股份。所有股票均以每股 0.065 美元的規定價格發行。股份是根據 NI 45-106 第 2.24 條所載的招股章程豁免發行，且不受任何限制性持有期限制。
About Aquarius Surgical Technologies Inc.
關於水瓶座外科技術公司
Aquarius Surgical Technologies is a provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines, principally in the field of urology. Solutions also include clinical education, service, support and maintenance. ASTI is focused on increasing the availability of services for patients, enhancing the quality of patient care, improving operationally efficiencies and reducing total operational costs.
水瓶座外科技術公司是一家為多個醫學領域提供創新的微創醫療激光系統和消耗品的提供商，主要是在泌尿科領域。解決方案還包括臨床教育、服務、支援和維護。ASTI 致力於提高患者服務的可用性，提高患者護理質量，提高運營效率並降低總營運成本。
For more information, please contact:
欲了解更多信息，請聯繫：
Gary Van Nest, co-CEO gary@sinaltainvestments.com
Lorne MacFarlance, CFO lornemac@eastlink.ca ; 902-496-7594
加里·范·內斯特, 聯席執行官 gary@sinaltainvestments.com
洛恩·麥克法蘭斯, 首席財務官 lornemac@eastlink.ca; 902-496-7594
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
加拿大證券交易所及其監管服務供應商（如加拿大證券交易所的政策中所定義）均不對此新聞稿的充分性或準確性承擔責任。
SOURCE: Aquarius Surgical Technologies Inc.
來源： 水瓶座手術技術公司
譯文內容由第三人軟體翻譯。